Smart insulin pump tested in kids with type 1 diabetes
NCT ID NCT05908708
First seen Apr 21, 2026 · Last updated Jun 22, 2026 · Updated 10 times
Summary
This study follows 120 Israeli children and teens with type 1 diabetes who are using the Medtronic 780G system, a device that combines an insulin pump with continuous glucose monitoring to automatically adjust insulin. Researchers want to see if it improves blood sugar control and quality of life over two years. Participants will be monitored at regular visits after starting the system.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sheba Medical Center
RECRUITINGRamat Gan, Please Select, 5265601, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Medtronic 780G hybrid closed-loop system (insulin pump with continuous glucose monitor)
What this could lead to
If successful, this could show that the 780G system helps youth with type 1 diabetes maintain better blood sugar levels and improve daily life.
What could go wrong
This is an observational study, not a controlled trial, so results may not prove cause and effect. It is also limited to Israeli children, so findings may not apply to all populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.